Aventus Capital Inc. (AVTS : TSX-V)
Common Stock
Follow AVTS
AVTS
Aventus Capital Inc.
Performance
1 Day
-5.01%
1 Week
+3.82%
1 Month
-13.69%
YTD
-22.25%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$617.68M
52W High
$27.60
52W Low
$16.35
P/E Ratio
-
50 Day MA
$19.46
200 Day MA
$22.35
Beta
-0.17
Dividend Yield
-
WA Score
How AVTS stacks up against 947 Canadian stocks
out of 99
- Value5
Not profitable over the last 12 months.
- Quality
- Momentum25
−22.2% this year, below its 200-day average, 12% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Earnings
AVTS earnings history
Aventus Capital Inc. beat the EPS estimate in 1 of its last 4 reported quarters.
Next report
Nov 12, 2026 · after close
EPS estimate −$0.21
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Mar 31, 2026 | May 14, 2026 | −$1.00 | −$0.33 | −203.0% |
| Jun 30, 2024 | Aug 13, 2024 | −$0.78 | −$0.66 | −18.2% |
| Dec 31, 2023 | Mar 27, 2024 | $1.56 | $2.28 | −31.6% |
| Sep 30, 2023 | Nov 14, 2023 | $0.96 | $0.84 | +14.3% |
| Jun 30, 2023 | Aug 15, 2023 | $1.33 | $1.44 | −7.6% |
| Sep 30, 2021 | Nov 18, 2021 | $0.06 | $0.36 | −83.3% |
| Jun 30, 2021 | Aug 19, 2021 | $0.48 | $0.36 | +33.3% |
| Dec 31, 2020 | Mar 25, 2021 | −$0.60 | $0.12 | −600.0% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past AVTS? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Aventus Capital Inc. insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Dec 31, 24 | Sell | Delaney, Ian William Individual | 5,755,341 | — |
| Dec 31, 24 | Sell | Delaney, Ian William Individual | 5,755,339 | — |
| Dec 31, 24 | Sell | Delaney, Ian William Individual | 1,572,885 | — |
| Dec 31, 24 | Sell | Delaney, Ian William Individual | 637 | — |
| Dec 31, 24 | Sell | Delaney, Ian William Individual | 762,500 | — |
| Dec 31, 24 | Sell | Delaney, Ian William Individual | 346,262 | — |
| Sep 05, 23 | Sell | Delaney, Ian William Individual · CA$167,320 | 47,000 | CA$3.56 |
| May 24, 23 | Buy | Delaney, Ian William Individual · CA$649,700 | 200,000 | CA$3.25 |
| May 19, 23 | Buy | Delaney, Ian William Individual · CA$155,000 | 50,000 | CA$3.10 |
| Apr 07, 21 | Buy | Delaney, Ian William Individual · CA$8,188 | 3,000 | CA$2.73 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $18.38 | $18.38 | $17.35 | $17.65 | $17.65 | 1,856 |
| 11/9/2026 | $18.20 | $18.67 | $18.09 | $18.58 | $18.58 | 4,701 |
| 11/6/2026 | $17.34 | $18.00 | $16.80 | $18.00 | $18.00 | 20,781 |
| 11/5/2026 | $16.57 | $16.90 | $16.35 | $16.90 | $16.90 | 9,720 |
| 11/4/2026 | $17.10 | $17.30 | $16.50 | $16.75 | $16.75 | 14,658 |
| 11/3/2026 | $17.35 | $17.35 | $17.00 | $17.00 | $17.00 | 8,136 |
| 11/2/2026 | $17.78 | $17.78 | $17.19 | $17.19 | $17.19 | 88,906 |
| 10/30/2026 | $17.85 | $18.08 | $17.58 | $17.87 | $17.87 | 7,061 |
| 10/29/2026 | $18.11 | $18.11 | $18.10 | $18.10 | $18.10 | 292 |
| 10/28/2026 | $18.25 | $18.50 | $18.17 | $18.33 | $18.33 | 5,912 |
Analyst Price Targets
Based on analyst covering AVTS · as of Nov 11, 2026
Wall Street analysts forecast AVTS stock price to rise 65.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$29.23
+65.6% Upside
Previously C$29.22 on Nov 9, 2026
Current Price
C$17.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVTS's historical volatility
30-Day Vol
45.6%
Annualized
90-Day Vol
52.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$14.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$16.63 | C$14.21 – C$19.46 |
| 60 trading days | C$15.67 | C$12.55 – C$19.57 |
| 90 trading days | C$14.76 | C$11.25 – C$19.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Aventus Capital Inc.
Aventus Capital Inc. is a private equity and venture capital firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mezzanine, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry including multi-sector holdings and specialized finance sectors. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm is an integrated insurance and alternative asset management company, purpose-built to deliver long-term value across the annuity and investment landscapes. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for 7 to 15 years. Aventus Capital Inc. was founded in 1996 and is based in Toronto, Canada with an additional office in New York, New York.
Financials
- Revenue (TTM)
- $61.51M
- EBITDA
- $-141.91M
- Profit Margin
- -236.02%
- ROE (TTM)
- -23.32%
- EPS (Diluted)
- -5.89
- Book Value
- 22.85
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About AVTS
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| NTLX | NeuroThera Labs Inc. | $3.60 | +123.60% |
| CTH | CoTec Holdings Corp. | $0.98 | +30.67% |
| IMI | Ironman International Ltd. | $0.07 | +30.00% |
| GCV | Golden Star Capital Ventures Inc. | $0.26 | +20.93% |
| LXM | Lux Metals Corp. | $0.17 | +20.69% |
| BEA | Belmont Resources Inc | $0.09 | +20.00% |
| BLU | BluEnergies Ltd. | $4.50 | +20.00% |
| MTS | Metallis Resources Inc. | $0.10 | +18.75% |
Free with a Wealth Awesome account
Keep analysing AVTS, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.